Biologic Characterization of Patients With ITP
- Conditions
- Immune Thrombocytopenia
- Interventions
- Other: peripheral blood and bone marrow withdrawal
- First Posted Date
- 2023-01-23
- Last Posted Date
- 2024-05-21
- Target Recruit Count
- 200
- Registration Number
- NCT05694325
- Locations
- 🇮🇹
Sc Ematologia Ospedale S.G. Battista Molinette - Università Degli Studi Di Torino, Torino, Italy
🇮🇹SC Ematologia ASUGI, Trieste, Italy
🇮🇹Ematologia e centro trapianti ASL Piacenza, Piacenza, Italy
Real World Evaluation of the Activity and Safety of Fostamatinib in Consecutive Adult Patients With ITP
- Conditions
- ITP - Immune ThrombocytopeniaChronic ITPRefractory ITP
- Interventions
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2025-04-30
- Target Recruit Count
- 95
- Registration Number
- NCT05613296
- Locations
- 🇮🇹
Aou Policlinico Tor Vergata Uoc Trapianto Cellule Staminali, Roma, Italy
🇮🇹Fondazione P.U. Agostino Gemelli Irccs - Area Ematologica, Roma, Italy
🇮🇹Divisione di Ematologia "Città della Salute e della Scienza di Torino", Torino, Italy
Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL
- Conditions
- High Risk CLLChronic Lymphocytic Leukemia
- Interventions
- Drug: VenObi+Ven or VenObi+VenZan
- First Posted Date
- 2022-07-28
- Last Posted Date
- 2023-11-18
- Target Recruit Count
- 78
- Registration Number
- NCT05478512
- Locations
- 🇮🇹
Ematologia Policlinico Gemelli, Roma, Italy
🇮🇹Ematologia AOUS - Policlinico S. M. alle Scotte, Siena, Italy
🇮🇹Ematologia Policlinico Umberto I, Roma, Italy
Ponatinib Plus Chemotherapy in Acute Lymphoblastic Leukemia Patients
- First Posted Date
- 2022-04-01
- Last Posted Date
- 2024-02-07
- Target Recruit Count
- 32
- Registration Number
- NCT05306301
- Locations
- 🇮🇹
Ematologia Policlinico A.Gemelli, Roma, Italy
🇮🇹Ematologia Ospedale S.Giovanni Battista Molinette, Torino, Italy
🇮🇹Ematologia AOU Federico II, Napoli, Italy
Use of nMoABs for the Treatment of COVID-19 in Patients With HM.
- Conditions
- Hematological MalignancyCovid19
- First Posted Date
- 2021-06-21
- Last Posted Date
- 2022-06-22
- Target Recruit Count
- 91
- Registration Number
- NCT04932967
- Locations
- 🇮🇹
Irccs Aou San Martino, Genova, Italy
🇮🇹Aou Pisana - Uo Ematologia Universitaria, Pisa, Italy
🇮🇹Ospedale Valduce - Uos Ematologia, Como, Italy
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
- Conditions
- MBL-CLL - Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukaemia-TypeSmall Lymphocytic LymphomaChronic Lymphocytic Leukemia
- First Posted Date
- 2021-04-30
- Last Posted Date
- 2025-03-14
- Target Recruit Count
- 12500
- Registration Number
- NCT04867915
- Locations
- 🇮🇹
Fondazione Del Piemonte Per L'Oncologia Centro Trapianti, Candiolo, Italy
🇮🇹SOD ematologia AOU Careggi, Firenze, Italy
🇮🇹UOC Ematologia AOU Policlinico "G. Martino", Messina, Italy
Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid Leukemia
- Conditions
- NPM1 MutationAcute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia
- Interventions
- Drug: Venetoclax+azacitidine
- First Posted Date
- 2021-04-30
- Last Posted Date
- 2022-03-16
- Target Recruit Count
- 35
- Registration Number
- NCT04867928
- Locations
- 🇮🇹
EMATOLOGIA- AOU Policlinico S.Orsola, Bologna, Italy
Trial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combination Including Decitabine and Venetoclax
- Conditions
- Acute Myeloid Leukemia
- Interventions
- Drug: Venetoclax+Decitabine
- First Posted Date
- 2021-02-21
- Last Posted Date
- 2024-11-08
- Target Recruit Count
- 101
- Registration Number
- NCT04763928
- Locations
- 🇮🇹
Ematologia A.O. SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
🇮🇹Ematologia AOU delle Marche, Ancona, Italy
🇮🇹Ematologia AOU Policlinico Bari, Bari, Italy
Investigation on the Incidence and Course of COVID-19 in Patients With Prior, Ongoing or de Novo ITP. Evaluation of the Impact of COVID-19 Pandemic on the Management of ITP
- Conditions
- Immune ThrombocytopeniaCovid19ITP Secondary to InfectionITP
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2022-08-26
- Target Recruit Count
- 140
- Registration Number
- NCT04735588
- Locations
- 🇮🇹
AOU Integrata Di Verona, Policlinico G.B. Rossi - UOC Ematologia, Verona, Italy
🇮🇹A.O.U. Careggi - Ematologia, Firenze, Italy
🇮🇹ASST Dei Sette Laghi - UOC Ematologia, Varese, Italy
Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL
- Conditions
- Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)ALL, AdultPhiladelphia-Positive ALL
- Interventions
- First Posted Date
- 2021-01-25
- Last Posted Date
- 2025-01-23
- Target Recruit Count
- 236
- Registration Number
- NCT04722848
- Locations
- 🇮🇹
Ente Ecclesiastico Casa Sollievo Della Sofferenza - San Giovanni Rotondo - Ematologia, San Giovanni Rotondo, Italy
🇮🇹Aou Senese - Uoc Ematologia E Trapianti, Siena, Italy
🇮🇹Asui Di Udine - Presidio Ospedaliero "Santa Maria Della Misericordia" - Clinica Ematologica, Udine, Italy